• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

82
7
7
7
2

COUNTRY

7
1

PRICE

14
16
24
118

PUBLISHED

1
4
10
118

PRODUCT TYPE

114
3
1

Breast Cancer

Over a million women worldwide are diagnosed with breast cancer annually. Alongside surgery, radiotherapy and immunotherapy, pharmaceutical products (including hormonal therapy and chemotherapy) are in the frontline against this terrible disease. Market reports in this section enable buyers to read up on the latest breast cancer drug pipelines and R&D strategies, as well as the medical and commercial activities of major players and niche operators such Abraxis Bioscience, Aeterna Zentaris, Agendia BV, Aphton Corp, Array BioPharma, AstraZeneca Plc, Bristol Myers Squibb, Dendreon Corporation, Eli Lilly, Genentech, Genta, Novartis AG, Pfizer, Roche Group, Sanofi-Aventis, Schering AG, Therion Biologics, and ViRexx Medical. Also included are cutting edge academic journals and various expert textbooks for medical professionals involved in breast cancer treatment. Show Less Read more

PRODUCT TITLE
Breast Cancer Drug Pathway Analyzer 2014 Breast Cancer Drug Pathway Analyzer 2014 - Product Thumbnail Image

Breast Cancer Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 532 targeted molecular therapies known to affect more than 253 specific intracellular signaling pathways...

July 2014
FROM

Global Breast Cancer Market 2014-2018

About Breast Cancer Breast cancer is characterized by the uncontrolled growth of cancerous cells in the breast tissue. It occurs in both males and females; however, male breast cancer is rare. Histologically,...

June 2014
FROM

Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

The leading business intelligence provider, has released its latest research, '‘Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance...

June 2014
FROM

Breast Cancer Treatment Drug Markets in China

China's demand for Breast Cancer Treatment Drug has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's...

June 2014
FROM
Analytical Tool - Breast Cancer Analytical Tool - Breast Cancer - Product Thumbnail Image

Analytical Tool - Breast Cancer

"Analytical Tool - Breast Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in breast cancer R&D and business development. It is at the same time...

March 2014
Breast Cancer: New Targeted Therapies Transform Treatment - KOL Insight Breast Cancer: New Targeted Therapies Transform Treatment - KOL Insight - Product Thumbnail Image

Breast Cancer: New Targeted Therapies Transform Treatment - KOL Insight

The introduction of targeted therapies revolutionised the breast cancer market, widening clinical options and bringing improved survival rates and lower side effects for patients Now the sector is set...

February 2014
FROM

EpiCast Report: Breast Cancer - Epidemiology Forecast to 2022

EpiCast Report: Breast Cancer - Epidemiology Forecast to 2022 Breast cancer is a malignant tumor that originates in the breast tissues According to the World Health Organization (WHO), breast cancer...

November 2013
FROM

Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth

The current market for breast cancer consists of five monoclonal Antibodies (mAbs), three of which are targeted at the Human Epidermal growth factor Receptor 2 (HER-2) protein Four are aimed at improving...

October 2013
FROM

Europe Breast Cancer Drug Pipeline Analysis

The pharmaceutical companies have recently been focusing increasingly on women's health Among the diseases specific to women, breast cancer has become one of the leading causes of death for the women...

October 2013
FROM

US Breast Cancer Drug Pipeline Analysis

The pharmaceutical companies have recently been focusing increasingly on women's health Among the diseases specific to women, breast cancer has become one of the leading causes of death for the women...

October 2013
FROM
Disease and Therapy Review: Breast Cancer Disease and Therapy Review: Breast Cancer - Product Thumbnail Image

Disease and Therapy Review: Breast Cancer

The Breast Cancer Disease and Therapy Review provides an overview of the disease and related conditions, with incidence, prevalence and mortality numbers and percentages for major countries worldwide,...

July 2013
FROM
Triple Analysis: Breast Cancer, Melanoma and Apoptosis Triple Analysis: Breast Cancer, Melanoma and Apoptosis - Product Thumbnail Image

Triple Analysis: Breast Cancer, Melanoma and Apoptosis

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated...

June 2013
FROM
Triple Analysis: Breast Cancer, Melanoma and Protein Kinase Inhibitors Triple Analysis: Breast Cancer, Melanoma and Protein Kinase Inhibitors - Product Thumbnail Image

Triple Analysis: Breast Cancer, Melanoma and Protein Kinase Inhibitors

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual...

June 2013
FROM
Triple Analysis: Breast Cancer, Colorectal Cancer and Melanoma Triple Analysis: Breast Cancer, Colorectal Cancer and Melanoma - Product Thumbnail Image

Triple Analysis: Breast Cancer, Colorectal Cancer and Melanoma

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Colorectal Cancer and Melanoma. Each of these three individual parts is evaluated according to standardized criteria...

June 2013
FROM
Triple Analysis: Breast Cancer, Melanoma and Prostate Cancer Triple Analysis: Breast Cancer, Melanoma and Prostate Cancer - Product Thumbnail Image

Triple Analysis: Breast Cancer, Melanoma and Prostate Cancer

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Melanoma and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria...

June 2013
FROM
Triple Analysis: Breast Cancer, Melanoma and Angiogenesis Triple Analysis: Breast Cancer, Melanoma and Angiogenesis - Product Thumbnail Image

Triple Analysis: Breast Cancer, Melanoma and Angiogenesis

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is evaluated...

June 2013
FROM
Triple Analysis: Breast Cancer, Leukemia and Melanoma Triple Analysis: Breast Cancer, Leukemia and Melanoma - Product Thumbnail Image

Triple Analysis: Breast Cancer, Leukemia and Melanoma

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Leukemia and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in a...

June 2013
FROM
Triple Analysis: Breast Cancer, Melanoma and Antibodies Triple Analysis: Breast Cancer, Melanoma and Antibodies - Product Thumbnail Image

Triple Analysis: Breast Cancer, Melanoma and Antibodies

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the compound strategy of Antibodies. Each of these three individual parts is evaluated according...

June 2013
FROM
Triple Analysis: Breast Cancer, Lung Cancer and Melanoma Triple Analysis: Breast Cancer, Lung Cancer and Melanoma - Product Thumbnail Image

Triple Analysis: Breast Cancer, Lung Cancer and Melanoma

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Lung Cancer and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in...

June 2013
FROM
Triple Analysis: Breast Cancer, Melanoma and Pancreatic Cancer Triple Analysis: Breast Cancer, Melanoma and Pancreatic Cancer - Product Thumbnail Image

Triple Analysis: Breast Cancer, Melanoma and Pancreatic Cancer

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Melanoma and Pancreatic Cancer. Each of these three individual parts is evaluated according to standardized criteria...

June 2013
FROM
Loading Indicator

Our Clients

Our clients' logos